Casi Pharmaceuticals Inc (CASI)

• $5.47

  $5.75

  $5.47
  

  0.0%

  Downside

  Day's Volatility :4.79%

  Upside

  4.79%

  
• $2.05

  $8.48

  $5.47
  

  62.52%

  Downside

  52 Weeks Volatility :75.83%

  Upside

  35.5%

  

Returns

What analysts predicted

Upside of 9.69%

• VR Adviser, LLC

  0.72%

• Wellington Shields Capital Mgmt LLC

  0.58%

• Wellington Shields & Co., LLC

  0.28%

• Renaissance Technologies Corp

  0.26%

• Geode Capital Management, LLC

  0.14%

• Howland Capital Management Inc

  0.10%

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market leveraging the Company’s China-based regulatory and commercial competencies and its global drug development expertise. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd. (“CASI China”), which is located in Beijing, China. The Company has built a commercial team of over 70 hematology and oncology sales and marketing specialists based in China.